RxDoctor Payments Data

Ashley Langford, APRN

Psychiatric/Mental Health · Pineville, KYNPI 1982331443

Payments from drug & device makers

$815in general payments, 2019–2025

Across 44 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$183
  • AbbVie$168
  • Teva Pharmaceuticals USA, Inc.$119
  • Alkermes, Inc.$117
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$41
  • Neurocrine Biosciences, Inc.$37
  • plus $149 from 6 others

What the payments were for

  • Food & beverage$815100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$815 in reported general payments places this provider in the 50th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$5,356
Medicare patients
15
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate15$35,327
BelsomraSuvorexant12$5,046
Quetiapine Fumarate75$1,497
Buspirone Hcl64$860
Aripiprazole43$826
Doxepin Hcl17$713
Bupropion XlBupropion Hcl51$534
Mirtazapine24$518
Trazodone Hcl56$371
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine18$312
Sertraline Hcl75$306
Lamotrigine18$207
Clonazepam47$188
Bupropion Hcl SrBupropion Hcl18$183
Prazosin Hcl16$183

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$23$35,32715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Pineville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →